Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study - Wikidata - awgldk - TriplyDB

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study

http://www.wikidata.org/entity/Q28364203

about

Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.Platinum drugs in the treatment of non-small-cell lung cancer Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates.Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors.A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor.

P2860

Q24652443-D417BF63-29BD-4AB1-8B93-AAABB020FCB1 Q28074716-E5DBBCBB-092D-4F3E-A0E1-8F877B47241A Q33367325-ABEC99CA-675A-48DA-BE21-EA59F5BD3A9C Q34954760-03FB172B-C097-4882-BFB9-F57C32DB2465 Q36444444-570067D8-D1CD-4AA0-91F4-6AB91FD8577C Q37634058-FA8843E6-21F3-4FA0-8D76-CB1C4E5F5EC3 Q38996621-B2699026-3F9B-47D5-A93C-500146D3B33A

P2860

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study

http://www.wikidata.org/entity/Q28364203

description

2001 nî lūn-bûn

@nan

2001 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@ast

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@en

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@nl

type

label

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@ast

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@en

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@nl

prefLabel

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@ast

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@en

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@nl

P1433

Q28364203-4BDB2989-BCB4-406C-8544-0BBA3218DF09

P1476

Q28364203-A3DE9BA0-F490-4129-A791-08772A1099C8

P2093

Q28364203-26247E48-32B6-453B-83E9-23499439D4E8

Q28364203-48BB91D5-4042-46E2-8D05-7A4C4AFA4812

Q28364203-75C66A68-CF0C-4AD0-AD91-60C39E1B155F

Q28364203-8B6608B1-ADBF-4FB8-81E4-96661983AFFB

Q28364203-B71131DB-CF3F-4505-8F4E-4A0E85480427

Q28364203-D2D04D1F-CD77-4C8D-A996-A13435A0E2AD

Q28364203-D5A5424B-8730-41AE-AF8D-C6E892E3BE18

Q28364203-EE18AE84-491D-41D3-A5F1-947F602E8E0C

Q28364203-F038F56B-9784-4499-9E0E-38B56FBCE9E5

P2860

Q28364203-1BB9FA60-0539-4A44-80D1-FF4FA9E72A50

Q28364203-24BF2E52-2994-47D3-8353-9709F59C13B5

Q28364203-275D41B4-928B-400F-BCCB-AE7C1D7D7903

Q28364203-2B0BB471-6528-4B04-A687-93EB2C2A01E6

Q28364203-2F1B66FF-A680-4CF3-A05D-D78129C9EA27

Q28364203-3BF0E680-9300-4675-8B45-111F6CA21F74

Q28364203-42CCA75C-F6FF-41C4-8CF3-2844F671E069

Q28364203-632F3887-7CAD-419C-9FE2-DDC941EF530E

Q28364203-768483DF-EB21-47D2-9BB4-B8CA110910E6

Q28364203-7974ECF0-CE3A-4F9B-8103-A9E887FAEE5F

P2888

Q28364203-DBFF05D6-C64D-4F2F-83A0-AA8AE331A69A

P304

Q28364203-0479BE5D-5191-4F51-BC4E-2BFC305C095E

P31

Q28364203-663C38BF-600C-4AA5-A56E-82C88DBF545D

P356

Q28364203-9E7C7F3C-47FE-41EA-8158-2842859903A7

P407

Q28364203-C0843F17-0288-419E-AEE4-1977CCC75CF0

P433

Q28364203-1AD430A0-F095-47D6-9ADA-79D9CAEE7E21

P478

Q28364203-CC666D2C-21F8-49FF-A422-C8B46C91159A

P577

Q28364203-626160A8-8892-4C64-8C93-C9685B3C8411

P5875

Q28364203-D46BCEC1-31F4-47B6-AB7E-63D6B0B2D36D

P6179

Q28364203-FBB6525A-EED4-411F-8D37-057DF7146E2E

P698

Q28364203-4B7D9E2F-B358-4FB9-A80B-73B0F997A6C3

P921

Q28364203-15AF8346-BC21-4659-B725-ED71B2CE965F

P932

Q28364203-FD1B55E5-26C6-4F8E-8FB5-E7800E040445

P356

P1433

British Journal of Cancer

P1476

Combined paclitaxel and gemcit ...... : a multicentre phase II study

@en

P2093

A M Haller

http://www.w3.org/2001/XMLSchema#string

A Monnier

http://www.w3.org/2001/XMLSchema#string

A Rivière

http://www.w3.org/2001/XMLSchema#string

B Grau

http://www.w3.org/2001/XMLSchema#string

D Assouline

http://www.w3.org/2001/XMLSchema#string

D Lerouge

http://www.w3.org/2001/XMLSchema#string

J Bennouna

http://www.w3.org/2001/XMLSchema#string

J Y Douillard

http://www.w3.org/2001/XMLSchema#string

X S Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Revisions in the International System for Staging Lung Cancer

Reporting results of cancer treatment

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.

Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group.

Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer.

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

P2888

P304

1179-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2001.1784

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12001292

http://www.w3.org/2001/XMLSchema#string

P6179

1045702449

http://www.w3.org/2001/XMLSchema#string

P698

11336467

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

2363882

http://www.w3.org/2001/XMLSchema#string